SEC 13F Intelligence

Tri Locum Partners LP / LEGN

Tri Locum Partners LP’s Legend Biotech Corp Position

Does Tri Locum Partners LP own Legend Biotech Corp (LEGN)? Not currently — the last reported position was 173.3K shares worth $6M in Q2 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$6M
Q2 2025
Shares
173.3K
% of Portfolio
+1.87%
Quarters Held
9
position exited

Position History LEGN

Reported value by quarter
Q3 ’21: $9MQ3 ’21Q4 ’21: $4MQ2 ’23: $8MQ2 ’23Q4 ’23: $6MQ1 ’24: $16MQ1 ’24Q2 ’24: $16MQ3 ’24: $18MQ3 ’24Q4 ’24: $13MQ2 ’25: $6MQ2 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2025173.3K$6M+1.87%
Q4 2024388.7K$13M+2.62%
Q3 2024362.3K$18M+4.23%
Q2 2024356.5K$16M+3.99%
Q1 2024283.8K$16M+5.52%
Q4 2023102.2K$6M+2.81%
Q2 2023116.8K$8M+3.00%
Q4 202189.8K$4M+1.65%
Q3 2021168.5K$9M+3.38%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Tri Locum Partners LP’s full portfolio or all institutional holders of LEGN.